Izzotti A - Search Results

1

MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome.

Speciale A, Monti P, Fronza G, Izzotti A, Menichini P. Speciale A, et al. Among authors: izzotti a. Microrna. 2020;9(5):322-335. doi: 10.2174/2211536609666201209151659. Microrna. 2020. PMID: 33297928 Review.

2

Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement.

D'Agostini F, Fronza G, Campomenosi P, Izzotti A, Petrilli GL, Abbondandolo A, De Flora S. D'Agostini F, et al. Among authors: izzotti a. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):111-5. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7742717

3

Lack of mutations in K-ras codons 12 and 13 in human atherosclerotic lesions.

Bogliolo M, Fronza G, Campomenosi P, Assereto P, Izzotti A, Petrilli GL, Abbondandolo A, De Flora S. Bogliolo M, et al. Among authors: izzotti a. Chem Biol Interact. 1996 Sep 27;102(1):55-62. doi: 10.1016/0009-2797(96)03731-3. Chem Biol Interact. 1996. PMID: 8827062

4

DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.

De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, Balansky R, van Schooten F, Degan P, Fronza G, Walsh D, Lewtas J. De Flora S, et al. Among authors: izzotti a. Mutat Res. 1996 Dec;366(3):197-238. Mutat Res. 1996. PMID: 9033668 Review.

5

Gene expression in the lung of p53 mutant mice exposed to cigarette smoke.

Izzotti A, Cartiglia C, Longobardi M, Bagnasco M, Merello A, You M, Lubet RA, De Flora S. Izzotti A, et al. Cancer Res. 2004 Dec 1;64(23):8566-72. doi: 10.1158/0008-5472.CAN-04-1420. Cancer Res. 2004. PMID: 15574763

6

The effects of environmental chemical carcinogens on the microRNA machinery.

Izzotti A, Pulliero A. Izzotti A, et al. Int J Hyg Environ Health. 2014 Jul;217(6):601-27. doi: 10.1016/j.ijheh.2014.01.001. Epub 2014 Jan 28. Int J Hyg Environ Health. 2014. PMID: 24560354 Review.

7

Prevention of Lymphocyte Neurotoxic Effects by microRNA Delivery.

Pulliero A, Marengo B, Fenoglio D, Parodi A, Cereda C, Domenicotti C, Orcesi S, Galli J, Olivieri I, Filaci G, Balottin U, Fazzi E, Izzotti A. Pulliero A, et al. Among authors: izzotti a. Microrna. 2014;2(3):187-93. doi: 10.2174/22115366113029990010. Microrna. 2014. PMID: 25069442

8

Molecular Damage in Glaucoma: from Anterior to Posterior Eye Segment. The MicroRNA Role.

Izzotti A, Ceccaroli C, Longobardi MG, Micale RT, Pulliero A, La Maestra S, Saccà SC. Izzotti A, et al. Microrna. 2015;4(1):3-17. doi: 10.2174/2211536604666150707124640. Microrna. 2015. PMID: 26149270 Review.

9

Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.

Colla R, Izzotti A, De Ciucis C, Fenoglio D, Ravera S, Speciale A, Ricciarelli R, Furfaro AL, Pulliero A, Passalacqua M, Traverso N, Pronzato MA, Domenicotti C, Marengo B. Colla R, et al. Among authors: izzotti a. Oncotarget. 2016 Oct 25;7(43):70715-70737. doi: 10.18632/oncotarget.12209. Oncotarget. 2016. PMID: 27683112 Free PMC article.

10

Preface: MicroRNA as Disease Biomarkers.

Pulliero A, Izzotti A. Pulliero A, et al. Among authors: izzotti a. Microrna. 2016;5(1):2-4. doi: 10.2174/221153660501160815185019. Microrna. 2016. PMID: 28105906 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters